![Emil Kakkis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 90 M $ al 30/06/2026
Emil D. Kakkis fundó Ultragenyx Pharmaceutical, Inc. y Everylife Foundation for Rare Diseases. El Dr. Kakkis ocupa el cargo de Presidente, Director General y Director de Ultragenyx Pharmaceutical, Inc. El Dr. Kakkis también forma parte del consejo de Emil Kakkis & Jenny Soriano Living Trust y de Odylia Therapeutics y es presidente de la Everylife Foundation for Rare Diseases. En su anterior carrera, el Dr. Kakkis fue director médico y vicepresidente senior de BioMarin Pharmaceutical, Inc. y profesor adjunto en el Centro Médico Harbor-UCLA. El Dr. Kakkis se licenció en el Pomona College y se doctoró en la Facultad de Medicina David Geffen.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/04/2026 | 2.694.724 ( 2,74 % ) | 90 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Fundador | 22/04/2010 |
Emil Kakkis & Jenny Soriano Living Trust | Director/Miembro de la Junta | - |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicates to accelerating rare disease treatments | Fundador | 01/03/2009 |
Odylia Therapeutics
 Odylia Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit biotech that develops therapies for rare diseases | Director/Miembro de la Junta | 01/01/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Director Técnico/Científico/I+D | 27/02/2009 |
Harbor-UCLA Medical Center
 Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Provides medical practice, education and research services | Corporate Officer/Principal | 01/01/1998 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
David Geffen School of Medicine
 David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Provides medical practice, education and research services | Health Services |
Emil Kakkis & Jenny Soriano Living Trust | |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization, which dedicates to accelerating rare disease treatments | Commercial Services |
Odylia Therapeutics
Odylia Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit biotech that develops therapies for rare diseases | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
